Cancer treatments which include conventional chemotherapy have not proven very
successful in curing human malignancies. The failures of these treatment modalities include …

NAMI-A ((ImH)[trans-RuCl4 (dmso-S)(Im)], Im= imidazole) and KP1019/1339
(KP1019=(IndH)[trans-RuCl4 (Ind) 2], Ind= indazole; KP1339= Na [trans-RuCl4 (Ind) 2]) are …

Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

Cancer is a heterogeneous and multifactorial disease that causes high mortality throughout
the world; therefore, finding the most effective therapies is a major research challenge …

Ruthenium-based complexes have a wide range of targets and mechanisms for anticancer
activities. For the treatment of malignant malignancy, ruthenium-based drugs have special …

The organometallic ruthenium (II)[Ru (arene) Cl2PTA] PTA‐1, 3, 5‐triaza‐7‐
phosphaadamantane compound, RAPTA‐C, represents an innovative anti‐cancer …

The leading first‐in‐class ruthenium‐complex BOLD‐100 currently undergoes clinical phase‐
II anticancer evaluation. Recently, BOLD‐100 is identified as anti‐Warburg compound. The …

Different studies about the anticancer potential of several medically used antibacterial
fluoroquinolones have been established. Fluoroquinolone derivatives, like some anti …

According to WHO, breast cancer incidence is increasing so that the search for novel
chemotherapeutic options is nowadays an essential requirement to fight neoplasm …

The incidence and mortality of cancer continue to grow since the current medical treatments
often fail to produce a complete and durable tumor response and ultimately give rise to …